Apellis Pharmaceuticals, Inc. (APLS)

23.64 +1.45 (+6.53%) USD  |  NASDAQ  |  Dec 05, 10:46
More

Apellis Pharmaceuticals EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade